source
- Oculis’ investigational eye drop OCS-01 fails Phase 3 trials for diabetic macular edema, shares tumbleOculis announced that its experimental eye drop OCS-01 did not meet primary endpoints in two Phase 3 studies aimed at treating diabetic macular edema. The trials were intended to evaluate the drug…
- ASCO meeting highlights grief alongside cancer data, honoring late oncologist Amy LinAt the annual American Society of Clinical Oncology meeting, scientists presented abundant new cancer data, but this year the program also gave space to the emotional side of oncology. Outgoing pr…